Arbutus Biopharma Corp Quarterly Entity Common Stock, Shares Outstanding from Q4 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Arbutus Biopharma Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2011 to Q3 2024.
  • Arbutus Biopharma Corp Entity Common Stock, Shares Outstanding for the quarter ending November 5, 2024 was 189M shares, a 13% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 189M +21.8M +13% Nov 5, 2024 10-Q 2024-11-06
Q2 2024 189M +21.2M +12.7% Aug 7, 2024 10-Q 2024-08-08
Q1 2024 189M +26.1M +16.1% Apr 30, 2024 10-Q 2024-05-02
Q3 2023 168M +11.2M +7.18% Nov 3, 2023 10-Q 2023-11-07
Q2 2023 168M +17.6M +11.7% Aug 1, 2023 10-Q 2023-08-03
Q1 2023 163M +13.9M +9.37% Feb 28, 2023 10-K 2023-03-02
Q3 2022 156M +21.2M +15.7% Nov 8, 2022 10-Q 2022-11-09
Q2 2022 150M +50.8M +51.2% Aug 2, 2022 10-Q 2022-08-04
Q1 2022 149M +53.1M +55.5% Mar 3, 2022 10-K 2022-03-03
Q3 2021 135M +50.4M +59.3% Nov 2, 2021 10-Q 2021-11-04
Q2 2021 99.2M +18.3M +22.6% Aug 3, 2021 10-Q 2021-08-05
Q1 2021 95.6M +26.6M +38.6% Mar 3, 2021 10-K 2021-03-04
Q3 2020 84.9M +28.1M +49.4% Nov 5, 2020 10-Q 2020-11-05
Q2 2020 80.9M +24.1M +42.3% Aug 5, 2020 10-Q 2020-08-07
Q1 2020 68.9M +12.8M +22.8% Mar 2, 2020 10-K 2020-03-05
Q3 2019 56.9M +1.37M +2.48% Oct 31, 2019 10-Q 2019-11-06
Q2 2019 56.9M +1.45M +2.61% Jul 31, 2019 10-Q 2019-08-05
Q1 2019 56.1M +1.05M +1.91% Mar 5, 2019 10-K 2019-03-07
Q3 2018 55.5M +425K +0.77% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 55.4M +377K +0.69% Jul 31, 2018 10-Q 2018-08-03
Q1 2018 55.1M +46.8K +0.09% Mar 6, 2018 10-K 2018-03-16
Q3 2017 55.1M +211K +0.38% Oct 31, 2017 10-Q 2017-11-02
Q2 2017 55M +230K +0.42% Jul 31, 2017 10-Q 2017-08-03
Q1 2017 55M +398K +0.73% Mar 14, 2017 10-K 2017-03-22
Q3 2016 54.8M +272K +0.5% Oct 31, 2016 10-Q 2016-11-03
Q2 2016 54.8M +468K +0.86% Jul 31, 2016 10-Q 2016-08-04
Q1 2016 54.6M +8.06M +17.3% Apr 30, 2016 10-Q 2016-05-04
Q3 2015 54.6M +32.5M +147% Oct 31, 2015 10-Q 2015-11-05
Q2 2015 54.3M +32.2M +146% Jul 31, 2015 10-Q 2015-08-07
Q1 2015 46.6M +24.6M +112% Mar 9, 2015 10-K 2015-03-13
Q3 2014 22.1M Nov 6, 2014 10-Q 2014-11-07
Q2 2014 22.1M Aug 12, 2014 10-Q 2014-08-14
Q1 2014 21.9M Mar 21, 2014 10-K 2014-03-28
Q4 2012 14.3M +2.16M +17.8% Dec 31, 2012 20-F 2013-03-27
Q4 2011 12.1M Dec 31, 2011 20-F 2012-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.